Kruis W - Search Results

1

Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16.

Curran ME, Lau KF, Hampe J, Schreiber S, Bridger S, Macpherson AJ, Cardon LR, Sakul H, Harris TJ, Stokkers P, Van Deventer SJ, Mirza M, Raedler A, Kruis W, Meckler U, Theuer D, Herrmann T, Gionchetti P, Lee J, Mathew C, Lennard-Jones J. Curran ME, et al. Among authors: kruis w. Gastroenterology. 1998 Nov;115(5):1066-71. doi: 10.1016/s0016-5085(98)70075-7. Gastroenterology. 1998. PMID: 9797359

2

Anticipation in inflammatory bowel disease: a phenomenon caused by an accumulation of confounders.

Hampe J, Heymann K, Kruis W, Raedler A, Fölsch UR, Schreiber S. Hampe J, et al. Among authors: kruis w. Am J Med Genet. 2000 May 29;92(3):178-83. doi: 10.1002/(sici)1096-8628(20000529)92:3<178::aid-ajmg4>3.0.co;2-p. Am J Med Genet. 2000. PMID: 10817651

3

Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease.

Schreiber S, Nikolaus S, Malchow H, Kruis W, Lochs H, Raedler A, Hahn EG, Krummenerl T, Steinmann G; German ICAM-1 Study Group. Schreiber S, et al. Among authors: kruis w. Gastroenterology. 2001 May;120(6):1339-46. doi: 10.1053/gast.2001.24015. Gastroenterology. 2001. PMID: 11313303 Clinical Trial.

4

Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate.

Schreiber S, Hämling J, Zehnter E, Howaldt S, Daerr W, Raedler A, Kruis W. Schreiber S, et al. Among authors: kruis w. Gut. 1997 Jun;40(6):761-6. doi: 10.1136/gut.40.6.761. Gut. 1997. PMID: 9245930 Free PMC article.

5

[Ulcerative colitis. Maintenance therapy].

Kruis W, Schreiber S. Kruis W, et al. Z Gastroenterol. 2004 Sep;42(9):1011-4. doi: 10.1055/s-2004-813494. Z Gastroenterol. 2004. PMID: 15455275 German. No abstract available.

6

Double-blind dose-finding study of olsalazine versus sulphasalazine as maintenance therapy for ulcerative colitis.

Kruis W, Judmaier G, Kayasseh L, Stolte M, Theuer D, Scheurlen C, Hentschel E, Kratochvil P. Kruis W, et al. Eur J Gastroenterol Hepatol. 1995 May;7(5):391-6. Eur J Gastroenterol Hepatol. 1995. PMID: 7614099 Clinical Trial.

7

Chronic inflammatory bowel disease and cancer.

Pohl C, Hombach A, Kruis W. Pohl C, et al. Among authors: kruis w. Hepatogastroenterology. 2000 Jan-Feb;47(31):57-70. Hepatogastroenterology. 2000. PMID: 10690586 Review.

8

[Biosimilars in inflammatory bowel disease].

Siegmund B, Atreya R, Bokemeyer B, Kruis W, Mudter J, Sander C, Schreiber S, Reindl W, Zeissig S, Kucharzik T. Siegmund B, et al. Among authors: kruis w. Z Gastroenterol. 2016 Nov;54(11):1217-1222. doi: 10.1055/s-0042-117648. Epub 2016 Oct 6. Z Gastroenterol. 2016. PMID: 27711946 Review. German.

9

Olsalazine in the treatment of mild to moderate ulcerative colitis: a randomized, placebo-controlled, double-blind, clinical trial.

Feurle GE, Theuer D, Velasco S, Barry BA, Wördehoff D, Sommer A, Jantschegk Y, Kruis W. Feurle GE, et al. Among authors: kruis w. Scand J Gastroenterol Suppl. 1988;148:38-9. doi: 10.3109/00365528809101545. Scand J Gastroenterol Suppl. 1988. PMID: 3067338 Clinical Trial.

10

Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis.

Kruis W, Brandes JW, Schreiber S, Theuer D, Krakamp B, Schütz E, Otto P, Lorenz-Mayer H, Ewe K, Judmaier G. Kruis W, et al. Aliment Pharmacol Ther. 1998 Aug;12(8):707-15. doi: 10.1046/j.1365-2036.1998.00360.x. Aliment Pharmacol Ther. 1998. PMID: 9726382 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

285 results

Search Page

Filters